To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period

NCT06904846 · clinicaltrials.gov ↗

NA

Phase

ENROLLING_BY_INVITATION

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus
Continuous Glucose Monitoring System

Interventions

DEVICE: iCan o3 CGM Continuous Glucose Monitoring System

Sponsor

Sinocare

Collaborators

[object Object]